Table 1.
Patient characteristics (N = 2304)
| Age, y a | 61.0 (52.0‐68.0) |
| Sex, male/female | 1174/1130 |
| AST, IU/L a | 42 (28‐70) |
| ALT, IU/L a | 45 (27‐80) |
| Albumin, g/dL a | 4.1 (3.8‐4.3) |
| Total bilirubin, mg/dL a | 0.6 (0.4‐0.8) |
| Prothrombin time, % a | 96.0 (85.0‐107.0) |
| Platelet count, × 104/mm3 a | 16.6 (12.5‐20.9) |
| α‐fetoprotein, ng/mL a | 3.9 (2.2‐8.0) |
| FIB‐4 index a | 2.4 (1.5‐4.1) |
| HCV genotype, 1/2/unknown | 1197/631/476 |
| HCV RNA, log10 IU/mL a | 5.6 (4.5‐6.1) |
| Follow‐up duration, y a | 10.7 (6.7‐15.0) |
| Development of HCC | 473 |
Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase; HCC, hepatocellular carcinoma; HCV, hepatitis C virus.
a
Values are expressed as medians (interquartile range).